Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
01 April 1993 to 15 April 1993
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1993
Report date:
1993

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
lithium sodium 2-amino-4-{[4-(cyanoazanidyl)-6-[(3-sulfonatophenyl)amino]-1,3,5-triazin-2-yl]amino}-5-(2-{4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)benzene-1-sulfonate
EC Number:
413-090-5
Cas Number:
189574-45-6
Molecular formula:
Hill formula: C24H18LixN10NayO12S4
IUPAC Name:
lithium sodium 2-amino-4-{[4-(cyanoazanidyl)-6-[(3-sulfonatophenyl)amino]-1,3,5-triazin-2-yl]amino}-5-(2-{4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)benzene-1-sulfonate
Test material form:
solid: particulate/powder
Details on test material:
See below

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
Test species: Wistar rat
Strain: Hoe: WISKf(SPF7l)
Source: HOECHST AG, Kastengrund, SPF breeding colony
Body Weight at start of study: males x = 178 g (= 100 %)
s = ± 2 g
x min = 177 g (- 0.6 %)
x max = 181 g (+ 1.7 %)
n = 5
females x = 176 g (= 100 %)
s = ± 4 g
x min = 170 g (- 3.4 %)
x max = 181 g (+ 2.8 %)
n = 5
Age at start of study: males approx. 7 weeks
females approx. 8 weeks
Randomisation: Randomisation schemes 404/92 and 617/92
Animal maintenance: in fully air-conditioned rooms in Makrolon cages (Type 4) on soft wood granulate in groups of 5 animals
Room temperature: 22 ± 3 ⁰C
Relative humidity: 55 + 20 %
Lighting time: 12 hours daily
Acclimatisation: not necessary (breeding at extensive identical conditions)
Withdrawal of food: from about 16 hours before to 3 - 4 hours after treatment
Food: Altromin 1324 rat diet (Altromin GmbH, Lage/Lippe), ad libitum
Water: tap water in plastic bottles, ad libitum
Animal identification: fur-marking with KMn04 and cage numbering

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
The acute oral toxicity of Reaktiv-Gelb F-68 072 FW was tested only at a dose level of 2000 mg/kg body weight.
Five male and five female rats received the test compound as a 20% suspension, the application volume being 10 ml/kg bodyweight.
If no compound-related mortality is produced in this limit test according to the guidelines no full study has to be carried out.

Reaktiv-Gelb F-68 072 FW was suspended in the stated concentration in deionised water and distributed homogeneously by means of a magnetic stirrer.
Doses:
2000 mg/kg body weight
No. of animals per sex per dose:
5 males
5 females
Control animals:
no
Details on study design:
The prepared test substance was administered by gavage to fasted animals at the stated dosage. The observation period following treatment lasted for 14 days. Symptoms were recorded twice every day (in the morning and in the afternoon), on weekends and holidays only once. During this time the animals were weighed weekly. At the end of the observation period the animals were killed by carbon dioxide asphyxiation, dissected and examined for macroscopically visible changes.

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No deaths occurred during the whole study.




Clinical signs:
other: The following clinical signs were observed after the application of Reaktiv-Gelb F-68 072 FW: decreased spontaneous activity, squatting posture, stilted gait, irregular respiration, bristling coat and sunken flanks. From the fourth day p.a. up to the end
Gross pathology:
The animals killed at the end of the observation period showed no macroscopically visible changes.
Other findings:
The faeces of all animals were mucous and discoloured orange.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Acute oral toxicity testing of Reaktiv-Gelb F-68 072 FW in the Wistar rat yielded a median lethal dose above 2000 mg/kg b,w. in both male and female animals.
Executive summary:

The present study was conducted in compliance with OECD Guidelines for Testing of Chemicals, 401"Acute Oral Toxicity"and EEC Guideline B.1, Acute Oral Toxicity in Council Directive 84/449/EEC. This study was conducted in compliance with the Principles of Good Laboratory Practice (GLP).

 

Acute oral toxicity testing of Reaktiv-Gelb F-68 072 FW in the Wistar rat yielded a median lethal dose above 2000 mg/kg b,w. in both male and female animals.

 

After application of 2000 mg/kg b.w. no deaths occurred.

 

Clinical signs were observed after application of 2000 mg/kg b.w.t consisting of decreased spontaneous activity, squatting posture, stilted gait, irregular respiration, bristling coat and sunken flanks. Furthermore the feces of all animals were mucous and discoloured orange.

From the fourth day p.a. up to the end of the study the animals were free of symptoms.

 

Development of body weight was not impaired.

 

The animals killed at the end of the observation period showed no macroscopically visible changes.